BCLI

0.753010.36%
JC

Jerold Chun

Chairman of Scientific Advisory Board

Dr. Jerold Chun, M.D., Ph.D., is the Chair of Scientific Advisory Board at Brainstorm Cell Therapeutics Inc. since March 12, 2018. Dr. Chun has been Member of Scientific Advisory Board at Travecta Therapeutics Pte Ltd. since November 2020. Dr. Chun is a Professor and Senior Vice President of Neuroscience Drug Discovery at Sanford Burnham Prebys Medical Institute and is an adjunct professor at the University of California San Diego School of Medicine, Departments of Pharmacology and Neurosciences. Dr. Chun serves as a Professor at The Scripps Research Institute in La Jolla, CA. Dr. Chun joined the medical school faculty of the University of California, San Diego, as full Professor (Pharmacology) in 2001. Dr. Chun served as the Senior Director and department head for Molecular Neuroscience, pursuing drug discovery programs at Merck & Co. Dr. Chun serves as Member of the Scientific Advisory Board of Amira Pharmaceuticals, Inc. He served as Member of Advisory Board at Aardvark Therapeutics, Inc. He serves on Editorial Boards for scientific journals and academic Advisory/Review boards for the NIH, Wellcome Trust, Deutsche Forschungsgemeinschaft, Biotechnology and Biological Research Council (UK), The Netherlands Organization for Health Research and Development, Genome British Columbia, Human Frontier Science Program, March of Dimes and Alzheimer's Association. He served as a senior director of Merck & Co. He has published over 150 manuscripts and received multiple awards and fellowships including support through the Medical Scientist Training Program; Grass, Helen Hay Whitney, Alfred P. Sloan, March of Dimes and Klingenstein Foundations and the National Institutes of Health (NIH). Among his achievements, he identified the first lysophospholipid receptor (1996), was first to demonstrate genomic mosaicism in the brain (2001) and its alteration in Alzheimer's disease (2015). Dr. Chun is a recipient of over a dozen awards, has published ~300 scientific articles and three patents. He received M.D. and a Ph.D. in Neurosciences from Stanford University, through the Medical Scientist Training Program in 1988. He completed his postdoctoral studies at the Whitehead Institute/Massachusetts Institute of Technology.

Positions